drugset / Trial / NCT05602129
A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is divided into Stage I and Stage II. It is planned to include 156 subjects who need CRRT treatment for more than 48 hours.
Timeline
- Start
- 2022-11
- Primary completion
- 2023-10
- Completion
- 2023-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK36273 | Unknown | — | — |
| Comparator | Heparin | Other / unclassified | — | — |
Indications
No indication recorded.